Peregrine Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Buy |
104,690
+3,493
| +3% | +$182K | 0.16% | 175 |
|
|
2025
Q1 | $6.11M | Buy |
101,197
+1,596
| +2% | +$96.4K | 0.2% | 151 |
|
|
2024
Q4 | $6.82M | Buy |
99,601
+1,750
| +2% | +$120K | 0.2% | 147 |
|
|
2024
Q3 | $7.04M | Buy |
97,851
+214
| +0.2% | +$15.4K | 0.21% | 139 |
|
|
2024
Q2 | $6.77M | Buy |
97,637
+1,244
| +1% | +$86.2K | 0.2% | 178 |
|
|
2024
Q1 | $7.72M | Sell |
96,393
-15
| -0% | -$1.2K | 0.22% | 140 |
|
|
2023
Q4 | $10.6M | Sell |
96,408
-16,079
| -14% | -$1.76M | 0.32% | 66 |
|
|
2023
Q3 | $11.3M | Sell |
112,487
-6,860
| -6% | -$692K | 0.34% | 74 |
|
|
2023
Q2 | $16.2M | Sell |
119,347
-39
| -0% | -$5.3K | 0.44% | 50 |
|
|
2023
Q1 | $12.4M | Buy |
119,386
+3,407
| +3% | +$354K | 0.36% | 79 |
|
|
2022
Q4 | $10.3M | Sell |
115,979
-3,407
| -3% | -$302K | 0.32% | 115 |
|
|
2022
Q3 | $9.57M | Sell |
119,386
-6,520
| -5% | -$523K | 0.31% | 128 |
|
|
2022
Q2 | $12.1M | Sell |
125,906
-34
| -0% | -$3.26K | 0.36% | 82 |
|
|
2022
Q1 | $18.7M | Sell |
125,940
-9,133
| -7% | -$1.36M | 0.44% | 47 |
|
|
2021
Q4 | $19.1M | Buy |
135,073
+3,761
| +3% | +$533K | 0.38% | 62 |
|
|
2021
Q3 | $17.2M | Sell |
131,312
-23,791
| -15% | -$3.11M | 0.36% | 69 |
|
|
2021
Q2 | $21.3M | Sell |
155,103
-6,987
| -4% | -$960K | 0.38% | 62 |
|
|
2021
Q1 | $21.2M | Sell |
162,090
-22,629
| -12% | -$2.96M | 0.39% | 74 |
|
|
2020
Q4 | $20.7M | Buy |
+184,719
| New | +$20.7M | 0.39% | 79 |
|